S
Silvia D. Stan
Researcher at Purdue University
Publications - 14
Citations - 1132
Silvia D. Stan is an academic researcher from Purdue University. The author has contributed to research in topics: Diallyl trisulfide & Cancer. The author has an hindex of 11, co-authored 12 publications receiving 1010 citations. Previous affiliations of Silvia D. Stan include University of Pittsburgh & South University.
Papers
More filters
Journal ArticleDOI
Withaferin A Causes FOXO3a- and Bim-Dependent Apoptosis and Inhibits Growth of Human Breast Cancer Cells In vivo
TL;DR: The WA treatment decreased viability of MCF-7 and MDA-MB-231 human breast cancer cells in a concentration-dependent manner and pointed toward an important role of FOXO3a and Bim in regulation of WA-mediated apoptosis in human breast cancers.
Journal ArticleDOI
Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
Shivendra V. Singh,Renaud Warin,Dong Xiao,Anna A. Powolny,Silvia D. Stan,Julie A. Arlotti,Yan Zeng,Eun-Ryeong Hahm,Stanley W. Marynowski,Ajay Bommareddy,Dhimant Desai,Shantu Amin,Robert A. Parise,Jan H. Beumer,William H. Chambers +14 more
TL;DR: The results of the present study indicate that SFN administration inhibits prostate cancer progression and pulmonary metastasis in TRAMP mice by reducing cell proliferation and augmenting NK cell lytic activity.
Journal ArticleDOI
Bioactive food components and cancer risk reduction.
TL;DR: Current knowledge on cancer chemopreventive effects of a few highly promising dietary constituents, including garlic‐derived organosulfides, berry compounds, and cruciferous vegetable‐derived isothiocyanates is reviewed, and serves to illustrate complexity of the signal transduction mechanisms in cancerChemoprevention by these promising bioactive food components.
Journal ArticleDOI
Ayurvedic Medicine Constituent Withaferin A Causes G2 and M Phase Cell Cycle Arrest in Human Breast Cancer Cells
TL;DR: The results of this study suggest that G2-M phase cell cycle arrest may be an important mechanism in antiproliferative effect of WA against human breast cancer cells.
Journal ArticleDOI
Chemoprevention strategies for pancreatic cancer
TL;DR: The current state of the pancreatic cancer chemopreventive field is discussed, the challenges ahead are highlighted and further development of pancreatic Cancer Chemoprevention agents may prove to be tremendously valuable for individuals at high risk of developing Pancreatic cancer and patients who present with premalignant lesions.